Neuland Laboratories Limited

Neuland Laboratories Limited (NEULANDLAB) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

neulandlabs.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹22890.00
Market cap
29,368 Cr
Stock P/E
66.5
P/B
15.67
Dividend yield
0.1%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales418 Cr393 Cr385 Cr440 Cr311 Cr398 Cr328 Cr293 Cr514 Cr440 Cr776 Cr642 Cr
Operating expenses (approx.)280 Cr272 Cr278 Cr316 Cr249 Cr311 Cr277 Cr258 Cr359 Cr363 Cr469 Cr419 Cr
EBITDA137 Cr121 Cr107 Cr123 Cr62 Cr87 Cr51 Cr34 Cr156 Cr77 Cr307 Cr223 Cr
OPM %32.9%30.9%27.8%28.1%20.0%21.8%15.6%11.8%30.2%17.5%39.6%34.7%
Other income3 Cr2 Cr5 Cr5 Cr4 Cr4 Cr7 Cr8 Cr2 Cr8 Cr12 Cr8 Cr
Interest4 Cr4 Cr4 Cr3 Cr1 Cr2 Cr2 Cr5 Cr5 Cr7 Cr7 Cr7 Cr
Depreciation15 Cr15 Cr16 Cr16 Cr16 Cr16 Cr17 Cr20 Cr23 Cr24 Cr25 Cr27 Cr
Profit before tax122 Cr104 Cr92 Cr130 Cr49 Cr128 Cr39 Cr18 Cr129 Cr54 Cr287 Cr198 Cr
Tax %26.6%22.1%26.7%24.6%33.5%20.5%29.2%20.9%25.2%25.5%26.0%25.4%
Net profit89 Cr81 Cr68 Cr98 Cr33 Cr102 Cr28 Cr14 Cr97 Cr41 Cr213 Cr148 Cr
EPS (₹)₹69.56₹63.44₹52.66₹76.28₹25.60₹79.18₹21.67₹10.83₹75.49₹31.62₹165.76₹115.10

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales667 Cr763 Cr937 Cr951 Cr1,191 Cr1,559 Cr1,477 Cr2,023 CrSign in for TTM
Operating expenses (approx.)608 Cr661 Cr790 Cr808 Cr919 Cr1,096 Cr1,154 Cr1,448 CrSign in for TTM
EBITDA58 Cr102 Cr147 Cr143 Cr272 Cr463 Cr323 Cr574 CrSign in for TTM
OPM %8.8%13.4%15.7%15.0%22.8%29.7%21.9%28.4%Sign in for TTM
Other income3 Cr4 Cr16 Cr2 Cr10 Cr13 Cr21 Cr30 CrSign in for TTM
Interest16 Cr22 Cr18 Cr13 Cr13 Cr14 Cr8 Cr24 CrSign in for TTM
Depreciation26 Cr31 Cr40 Cr49 Cr53 Cr60 Cr66 Cr92 CrSign in for TTM
Profit before tax20 Cr53 Cr105 Cr82 Cr216 Cr401 Cr346 Cr489 CrSign in for TTM
Tax %19.2%69.4%23.5%22.3%24.2%25.2%24.9%25.6%Sign in for TTM
Net profit16 Cr16 Cr81 Cr64 Cr164 Cr300 Cr260 Cr364 CrSign in for TTM
EPS (₹)₹13.06₹12.63₹62.85₹49.74₹127.45₹233.89₹202.74₹283.71Sign in for TTM
Dividend payout %———6.0%3.9%4.3%6.9%4.2%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital13 Cr13 Cr13 Cr13 Cr13 Cr13 Cr13 Cr13 Cr
Reserves686 Cr697 Cr774 Cr828 Cr981 Cr1,270 Cr1,512 Cr1,862 Cr
Borrowings210 Cr246 Cr145 Cr231 Cr122 Cr83 Cr136 Cr197 Cr
Other liabilities221 Cr275 Cr393 Cr312 Cr464 Cr467 Cr519 Cr859 Cr
Total liabilities1,130 Cr1,231 Cr1,325 Cr1,383 Cr1,580 Cr1,833 Cr2,180 Cr2,930 Cr
Fixed assets (net)230 Cr337 Cr402 Cr457 Cr457 Cr523 Cr674 Cr892 Cr
CWIP104 Cr24 Cr17 Cr20 Cr41 Cr46 Cr45 Cr209 Cr
Investments38 Cr38 Cr25 Cr24 Cr20 Cr20 Cr109 Cr2 Cr
Inventories193 Cr220 Cr248 Cr265 Cr279 Cr350 Cr386 Cr510 Cr
Trade receivables164 Cr190 Cr218 Cr234 Cr362 Cr374 Cr316 Cr541 Cr
Cash & bank8 Cr11 Cr2 Cr5 Cr45 Cr88 Cr132 Cr77 Cr
Other assets393 Cr411 Cr413 Cr378 Cr375 Cr432 Cr519 Cr698 Cr
Total assets1,130 Cr1,231 Cr1,325 Cr1,383 Cr1,580 Cr1,833 Cr2,180 Cr2,930 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———59 Cr237 Cr261 Cr317 Cr347 Cr
Cash from investing———-94 Cr-61 Cr-150 Cr-298 Cr-424 Cr
Cash from financing———38 Cr-136 Cr-69 Cr25 Cr21 Cr
Net cash flow———3 Cr40 Cr42 Cr44 Cr-55 Cr
Free cash flow (OCF − Capex)———-37 Cr171 Cr118 Cr111 Cr-50 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %4.0%7.8%15.7%8.9%20.5%30.4%21.4%24.8%
ROE %2.4%2.3%10.3%7.9%16.4%0.0%0.0%19.4%
Debtor days90918590111877897
Inventory days195205205221208202244227
Days payable12310812693128111160120
Cash conversion cycle161188164217191179162204
Debt / equity0.300.350.180.270.120.060.090.10
Current ratio1.391.441.491.601.732.152.452.09
Net debt / EBITDA3.460.000.000.000.28-0.010.010.21

Compare with peers

Loading peers…